- Generic name
- Ondansetron
- Strength
- 4 mg
- Dosage form
- Tablet
- Manufactured by
- Albion Laboratories Ltd.
Emofast FT Tablet
About Emofast FT 4 mg Tablet
The tablet Emofast FT contains Ondansetron and is made by Albion Laboratories Ltd. Emofast FT 4 mg tablet is used to prevent nausea and vomiting from emetogenic cancer chemotherapy, including repeat courses.
There are 74 brands of Ondansetron listed in Bangladesh. The lowest listed price is Periset 16 mg Suppository at ৳ 1 per unit.
What is Emofast FT 4 mg Tablet?
Emofast FT is a tablet from Albion Laboratories Ltd., with the generic name Ondansetron. It belongs to a group called anti-emetic drugs, which are used to manage nausea and vomiting. It is prescribed to help prevent nausea and vomiting linked to some cancer chemotherapy, radiotherapy and surgery. The doctor decides whether it is suitable, the dose and the length of the course.
Uses of Emofast FT
Emofast FT 4 mg tablet is used to prevent nausea and vomiting from emetogenic cancer chemotherapy, including repeat courses. A doctor decides whether it is suitable for a particular situation. It is also used to prevent nausea and vomiting caused by radiotherapy. Your doctor will decide if it fits your situation.
How to use Emofast FT
If you are unsure about anything, ask your doctor or pharmacist rather than changing the schedule yourself. Swallow the tablet with water. Emofast FT is taken by mouth. Do not take more than prescribed. Complete the course exactly as prescribed. Do not change the dose or stop the course on your own.
Side effects of Emofast FT
Some people may notice a feeling of flushing or warmth, hiccups, or changes in liver enzyme tests. Like all medicines, Emofast FT tablet can cause side effects. Rarely, serious allergic reactions, breathing problems, fast heartbeat, chest pain, and low potassium have been reported. Tell your doctor if you notice any side effect, especially one that is severe or does not go away.
Safety and precautions
There is not enough information about its use in pregnancy; ask your doctor before taking it if you are pregnant, planning to become pregnant, or breastfeeding. Anyone with heart, liver or other health problems should check with the doctor first. Your doctor will decide if it is right for you.
Frequently asked questions
Why is Emofast FT prescribed?
Emofast FT 4 mg tablet is used to prevent nausea and vomiting from emetogenic cancer chemotherapy, including repeat courses. A doctor decides whether it is suitable for a particular situation.
How is Emofast FT used?
If you are unsure about anything, ask your doctor or pharmacist rather than changing the schedule yourself. Swallow the tablet with water.
What are the side effects of Emofast FT?
Some people may notice a feeling of flushing or warmth, hiccups, or changes in liver enzyme tests. Like all medicines, Emofast FT tablet can cause side effects.
Can I use Emofast FT in pregnancy or while breastfeeding?
There is not enough information about its use in pregnancy; ask your doctor before taking it if you are pregnant, planning to become pregnant, or breastfeeding. Anyone with heart, liver or other health problems should check with the doctor first.
Indications
- Prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy.
- Prevention and treatment of post-operative nausea and vomiting.
- Prevention of radiotherapy-induced nausea and vomiting.
Pharmacology
Dosage & Administration
Adults, Pediatric patients (6 months to 18 years):
- 8 mg tablet/orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Adults:
- 8 mg tablet/orodispersible tablet: Initial Dose: 8 mg orally 1 to 2 hours before radiotherapy. Post Radiotherapy: 8 mg orally every 8 hours for up to 5 days after a course of treatment.
- 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Adults:
- 8 mg tablet/orodispersible tablet: 16 mg given as two 8 mg tablets
- 4 mg orodispersible tablet: 16 mg
- Injection: 4 mg
Pediatrics (40 kg): Injection: 0.1 mg/kg
Chemotherapy-induced Nausea and Vomiting-
Adults/Geriatric/Child of 12 years or over:
- Highly emetogenic cancer chemotherapy: 30 ml (24 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy.
- Moderate emetogenic cancer chemotherapy: 10 ml (8 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy. A further 10 ml dose should be administered after 8 hours of the first dose. One 10 ml dose should be administered twice a day (every 12 hours) for 1-2 days after completion of chemotherapy.
Oral solution:
Radiotherapy induced Nausea and Vomiting (Adults/Geriatric/Child of 12 years or over):- The recommended oral dosage: 10 ml (8 mg) Ondansetron Oral Solution 3 times daily.
- For total body irradiation: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before each fraction of radiotherapy administered each day.
- For single high-dose fraction radiotherapy to the abdomen: one 10 ml Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for 1 to 2 days after completion of radiotherapy.
- For daily fractionated radiotherapy to the abdomen: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for each day radiotherapy is given.
- 20 ml (16 mg) Ondansetron Oral Solution 1 hour before induction of anesthesia
Oral Soluble Film:
Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy:- Adult oral dose: 24 mg given successively as three 8 mg films 30 minutes before the start of chemotherapy.
- Adults and pediatric patients 12 years of age and older: One 8 mg film 30 minutes before chemotherapy followed by an 8 mg dose 8 hours later. Administer one 8 mg film twice a day (every 12 hours) for 1 to 2 days after completion of chemotherapy.
- Pediatric patients 4 through 11 years of age: One 4 mg film three times a day. Administer the first dose 30 minutes before chemotherapy, with subsequent doses 4 and 8 hours later. Administer one 4 mg film three times a day (every 8 hours) for 1 to 2 days after completion of chemotherapy.
- Prevention of nausea and vomiting associated with radiotherapy: The adult dosage is one 8 mg film three times a day.
- Postoperative nausea and vomiting: The adult dose is 16 mg given successively as two 8 mg films 1 hour before anesthesia.
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Reproduction studies have been performed in pregnant rats and rabbits at daily oral doses up to 15 and 30 mg/kg per day, respectively, and have revealed no evidence of impaired fertility or harm to the fetus due to Ondansetron. There are, however, no adequate and well-controlled studies in pregnant women. Ondansetron is excreted in the breast milk of rats. So caution should be exercised when Ondansetron is administered to a nursing women.
Precautions & Warnings
Storage Conditions
Alternative brands of Ondansetron
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.